{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:36:32Z","timestamp":1791218192352,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["MCT\/CNPq\/MS-SCITIE-DECIT 25\/2006"],"award-info":[{"award-number":["MCT\/CNPq\/MS-SCITIE-DECIT 25\/2006"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2700-6","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T01:20:29Z","timestamp":1504660829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-na\u00efve patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Tatiana Pereira","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmem Beatriz Wagner","family":"Giacoia-Gripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina A.","family":"Schmaltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Marinho","family":"Sant\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Arruda de","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Castro Alves","family":"de Lima e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Cavalcanti","family":"Rolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza Gon\u00e7alves","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/QAD.0b013e32832d53e7","volume":"23","author":"R Wood","year":"2009","unstructured":"Wood R, Lawn SD, Bekker L-G. Are the effects of isoniazid preventive therapy and highly active antiretroviral therapy additive in preventing HIV-associated tuberculosis? AIDS. 2009;23:1444\u20136.","journal-title":"AIDS"},{"key":"2700_CR2","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI117611","volume":"94","author":"M Zhang","year":"1994","unstructured":"Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest. 1994;94:2435\u201342.","journal-title":"J Clin Invest"},{"key":"2700_CR3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QAI.0b013e3181b31e56","volume":"52","author":"CAS Schmaltz","year":"2009","unstructured":"Schmaltz CAS, Sant\u2019Anna FM, Neves SC, Velasque LDS, Louren\u00e7o MC, Morgado MG, et al. Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro. Brazil J Acquir Immune Defic Syndr. 2009;52:623\u20138.","journal-title":"Brazil J Acquir Immune Defic Syndr"},{"key":"2700_CR4","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.aids.0000279705.24428.a3","volume":"21","author":"DB Greco","year":"2007","unstructured":"Greco DB, Sim\u00e3o M. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives. AIDS. 2007;21:S37\u201345.","journal-title":"AIDS"},{"key":"2700_CR5","volume-title":"Programa Nacional de Controle de Doen\u00e7as Sexualmante Transmissiveis\/Aids","author":"Minist\u00e9rio da sa\u00fade- Brazil","year":"2001","unstructured":"Minist\u00e9rio da sa\u00fade- Brazil. Programa Nacional de Controle de Doen\u00e7as Sexualmante Transmissiveis\/Aids. 2001."},{"key":"2700_CR6","unstructured":"CDC. Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis [Internet]. 2014 [cited 2016 Nov 4]. Available from: \nhttp:\/\/www.cdc.gov\/tb\/publications\/guidelines\/tb_hiv_drugs\/recommendations02.htm"},{"key":"2700_CR7","first-page":"754","volume":"38","author":"S Carrara","year":"2004","unstructured":"Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T Cell \u2013 Based Assay for Monitoring Efficacy of Antituberculosis Therapy. 2004;38:754\u20136.","journal-title":"Use of a T Cell \u2013 Based Assay for Monitoring Efficacy of Antituberculosis Therapy"},{"key":"2700_CR8","doi-asserted-by":"crossref","first-page":"e5187","DOI":"10.1371\/journal.pone.0005187","volume":"4","author":"I Sauzullo","year":"2009","unstructured":"Sauzullo I, Mengoni F, Lichtner M, Massetti AP, Rossi R, Iannetta M, et al. In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. PLoS One. 2009;4:e5187.","journal-title":"PLoS One"},{"key":"2700_CR9","first-page":"674","volume":"180","author":"KA Wilkinson","year":"2009","unstructured":"Wilkinson KA, Seldon R, Meintjes G, Rangaka MX, Hanekom WA, Maartens G, et al. Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 2009;180:674\u201383.","journal-title":"Care Med"},{"key":"2700_CR10","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","volume":"167","author":"AA Pathan","year":"2001","unstructured":"Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, et al. Direct Ex Vivo Analysis of Antigen-Specific IFN- -Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment. J Immunol. 2001;167:5217\u201325.","journal-title":"J Immunol"},{"key":"2700_CR11","unstructured":"ClinicalTrials.gov. p. \nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT00533390\n\n."},{"key":"2700_CR12","volume-title":"Boletim Epidemiol\u00f3gico AIDS\/DST. Aids","author":"Minist\u00e9rio da Sa\u00fade- Brazil","year":"2011","unstructured":"Minist\u00e9rio da Sa\u00fade- Brazil. Boletim Epidemiol\u00f3gico AIDS\/DST. Aids. 2011."},{"key":"2700_CR13","unstructured":"Minist\u00e9rio da sa\u00fade- Brazil. Boletim Epidemiol\u00f3gico \u2013 Volume 43 \u2013 Especial Tuberculose. Secr. Vigil\u00e2ncia em Sa\u00fade. 2012."},{"key":"2700_CR14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","volume":"42","author":"J Robertson","year":"2006","unstructured":"Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42:1639\u201346.","journal-title":"Clin Infect Dis"},{"key":"2700_CR15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/CVI.00387-05","volume":"13","author":"A Samri","year":"2006","unstructured":"Samri A, Durier C, Urrutia A, Sanchez I, Gahery-Segard H, Imbart S, et al. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol. 2006;13:684\u201397.","journal-title":"Clin Vaccine Immunol"},{"key":"2700_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v015.i02","volume":"15","author":"U Halekoh","year":"2006","unstructured":"Halekoh U, H\u00f8jsgaard S, Yan J. The R Package geepack for generalized estimating equations. J Stat Softw. 2006;15:1\u201311.","journal-title":"J Stat Softw"},{"key":"2700_CR17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761\u201376.","journal-title":"Lancet Infect Dis"},{"key":"2700_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2249.2007.03462.x","volume":"150","author":"D Vincenti","year":"2007","unstructured":"Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, Girardi E, et al. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol. 2007;150:91\u20138.","journal-title":"Clin Exp Immunol"},{"key":"2700_CR19","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/01.aids.0000202648.18526.bf","volume":"20","author":"A Bourgarit","year":"2006","unstructured":"Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, Gicquel B, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS. 2006;20:F1\u20137.","journal-title":"AIDS"},{"key":"2700_CR20","first-page":"252","volume":"90","author":"ND Marin","year":"2010","unstructured":"Marin ND, Par\u00eds SC, V\u00e9lez VM, Rojas CA, Rojas M, Garc\u00eda LF. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb). Elsevier Ltd. 2010;90:252\u201361.","journal-title":"Elsevier Ltd"},{"key":"2700_CR21","doi-asserted-by":"crossref","first-page":"e71351","DOI":"10.1371\/journal.pone.0071351","volume":"8","author":"HP Gideon","year":"2013","unstructured":"Gideon HP, Hamilton MS, Wood K, Pepper D, Oni T, Seldon R, et al. Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assay. PLoS One. 2013;8:e71351.","journal-title":"PLoS One"},{"key":"2700_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1348-0421.2007.tb03910.x","volume":"51","author":"RCO Tavares","year":"2007","unstructured":"Tavares RCO, Salgado J, Moreira VB, Ferreira MAS, Mello FCQ, Leung JW, et al. Interferon gamma response to combinations 38 kDa\/CFP-10, 38 kDa\/MPT-64, ESAT-6\/MPT-64 and ESAT-6\/CFP-10, each related to a single recombinant protein of Mycobacterium tuberculosis in individuals from tuberculosis endemic areas. Microbiol Immunol. 2007;51:289\u201396.","journal-title":"Microbiol Immunol"},{"key":"2700_CR23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/infdis\/166.4.874","volume":"166","author":"M Harboe","year":"1992","unstructured":"Harboe M, Wiker HG. The 38-kDa Protein of Mycobacterium tuberculosis: A Review. J Infect Dis. 1992;166:874\u201384.","journal-title":"J Infect Dis"},{"key":"2700_CR24","doi-asserted-by":"crossref","unstructured":"Carpenter C, Sidney J, Kolla R, Nayak K, Tomiyama H, Tomiyama C, et al. A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents. Tuberculosis. 2015;95:713\u201321.\u00a0","DOI":"10.1016\/j.tube.2015.07.001"},{"key":"2700_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/524685","volume":"197","author":"AS Hammond","year":"2008","unstructured":"Hammond AS, McConkey SJ, Hill PC, Crozier S, Klein MR, Adegbola RA, et al. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. J Infect Dis. 2008;197:295\u20139.","journal-title":"J Infect Dis"},{"key":"2700_CR26","unstructured":"Mazurek GH, MD, Jereb J, Vernon A, LoBue P GSCK. Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection. Centers Dis Control Prev. 2010;59:1\u201325."},{"key":"2700_CR27","unstructured":"Organization WH. Tuberculosis (TB) [Internet]. [cited 2017 Jan 1]. Available from: \nhttp:\/\/www.who.int\/tb\/areas-of-work\/population-groups\/gender\/en\/\n\n."},{"key":"2700_CR28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ajhb.22332","volume":"25","author":"NO Nielsen","year":"2013","unstructured":"Nielsen NO, Soborg B, B\u00f8rresen M, Andersson M, Koch A. Cytokine responses in relation to age, gender, body mass index, Mycobacterium tuberculosis infection, and otitis media among inuit in greenland. Am J Hum Biol. 2013;25:20\u20138.","journal-title":"Am J Hum Biol"},{"key":"2700_CR29","first-page":"362","volume":"63","author":"OH Cho","year":"2011","unstructured":"Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, et al. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Inf Secur. 2011;63:362\u20139.","journal-title":"J Inf Secur"},{"key":"2700_CR30","doi-asserted-by":"crossref","unstructured":"Blanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis. N Engl J Med. 2011;365:1471\u201381.","DOI":"10.1056\/NEJMoa1013911"},{"key":"2700_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e31829f6df2","volume":"64","author":"R Vignesh","year":"2013","unstructured":"Vignesh R, Kumarasamy N, Lim A, Solomon S, Murugavel KG, Balakrishnan P, et al. TB-IRIS After Initiation of Antiretroviral Therapy Is Associated With Expansion of Preexistent Th1 Responses Against Mycobacterium tuberculosis Antigens. J Acquir Immune Defic Syndr. 2013;64:241\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2700_CR32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"DV Havlir","year":"2011","unstructured":"Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482\u201391.","journal-title":"N Engl J Med"},{"key":"2700_CR33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200241090-00004","volume":"41","author":"LF L\u00f3pez-Cort\u00e9s","year":"2002","unstructured":"L\u00f3pez-Cort\u00e9s LF, Ruiz-Valderas R, Viciana P, Alarc\u00f3n-Gonz\u00e1lez A, G\u00f3mez-Mateos J, Le\u00f3n-Jimenez E, Sarasanacenta M, L\u00f3pez-Pua YPJ. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis. Clin Pharmacokinet. 2002;41:681\u201390.","journal-title":"Clin Pharmacokinet"},{"key":"2700_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.aids.0000196181.18916.9b","volume":"20","author":"W Manosuthi","year":"2006","unstructured":"Manosuthi W, Kiertiburanakul S, Sungkanuparph S, Ruxrungtham K, Vibhagool A, Rattanasiri S, et al. Efavirenz 600 mg\/day versus efavirenz 800 mg\/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results. AIDS. 2006;20:131\u20132.","journal-title":"AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T01:20:49Z","timestamp":1504660849000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2700-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"article-number":"606"}}